Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Akt1 S897-p
EphA2 Y575-p , Y588-p , Y594-p , Y628-p , Y694-p , Y735-p , Y772-p , Y921-p , Y960-p
p90RSK S897-p
RSK2 S897-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

EphA2 Y588-p , Y594-p , Y735-p , Y772-p
p90RSK S897-p
RSK2 S897-p
Phosphatases, in vitro:
PTPRF Y930-p
Putative upstream phosphatases:
ACP1 Y575-p , Y588-p , Y594-p , Y772-p , Y960-p
Regulatory protein:
CSFR Y575-p , Y588-p , T593-p , Y594-p , Y772-p
EGFR Y575-p , Y594-p , Y772-p
FGFR1 Y772-p
TAK1 S897-p
TBK1 S897-p
Treatment:
ALW-II-41-27 Y588-p , S897-p
angiotensin_2 S897-p , S901-p
BI-D1870 S897-p
crizotinib S897-p
dasatinib Y772-p
EGF Y575-p , Y772-p , S892-p , S897-p , S899-p , S901-p
ephrin_A1 Y588-p , Y594-p , Y735-p , Y772-p , S897-p
ephrin_B1 Y588-p , Y594-p , Y772-p
ephrin_B2 Y588-p , Y594-p , Y772-p
FGF2 T587-p , Y594-p , Y772-p , S897-p
gefitinib Y588-p , Y594-p , S897-p , Y960-p
HGF Y588-p , Y594-p , Y772-p , S897-p
ischemia S897-p
LPA S897-p
LY294002 S897-p
metastatic potential S897-p , S899-p , S901-p
MG132 Y772-p , S897-p
MG132_withdrawal Y772-p
MK-2206 S897-p
nocodazole S570-p , Y575-p , S579-p , T647-p
PD166866 S897-p
PDGF S897-p
phorbol_ester S897-p
SB202190 S897-p , S899-p , S901-p
selumetinib S897-p , S901-p
serum S897-p
Su11274 Y575-p , Y588-p , Y594-p , Y772-p , S892-p , S897-p , T898-p , S899-p , S901-p , Y921-p
SU5402 S897-p
thymidine S570-p , Y575-p , S579-p , T647-p
TNF S897-p
U0126 S897-p , S901-p
vemurafenib S897-p , S901-p